Good deal dude!
Volumina is up for FDA approval. You have to really do your homework on this hybrid-pharma to understand their business.
I doubled down too. AGN is beating their competitors silly, and snagging market share from it's competitors.
I just love sector leaders who show this kind of moxie!
There is so much more good stuff going on with AGN, that I will hold for the long haul, and buy any weakness!